[HTML][HTML] SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity

S Pilz, V Theiler-Schwetz, C Trummer, R Krause… - Environmental …, 2022 - Elsevier
Seroprevalence surveys suggest that more than a third and possibly more than half of the
global population has been infected with SARS-CoV-2 by early 2022. As large numbers of …

COVID-19 vaccine strategies must focus on severe disease and global equity

PB McIntyre, R Aggarwal, I Jani, J Jawad, S Kochhar… - The Lancet, 2022 - thelancet.com
In September, 2020, the WHO Prioritisation Roadmap for COVID-19 vaccines gave priority to
prevention of severe disease and the highest risk groups. In July, 2021, the revised …

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants

TA Bates, SK McBride, HC Leier, G Guzman… - Science …, 2022 - science.org
Current coronavirus disease 2019 (COVID-19) vaccines effectively reduce overall morbidity
and mortality and are vitally important to controlling the pandemic. Individuals who …

[HTML][HTML] Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in …

P Nordström, M Ballin, A Nordström - The Lancet Infectious Diseases, 2022 - thelancet.com
Background Real-world evidence supporting vaccination against COVID-19 in individuals
who have recovered from a previous SARS-CoV-2 infection is sparse. We aimed to …

Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity

LB Rodda, PA Morawski, KB Pruner, ML Fahning… - Cell, 2022 - cell.com
Immune memory is tailored by cues that lymphocytes perceive during priming. The severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic created a situation in …

The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism

BJ Willett, J Grove, OA MacLean, C Wilkie, N Logan… - MedRxiv, 2022 - medrxiv.org
Vaccination-based exposure to spike protein derived from early SARS-CoV-2 sequences is
the key public health strategy against COVID-19. Successive waves of SARS-CoV-2 …

Necessity of coronavirus disease 2019 (COVID-19) vaccination in persons who have already had COVID-19

NK Shrestha, PC Burke, AS Nowacki… - Clinical Infectious …, 2022 - academic.oup.com
Background The aim was to evaluate the necessity of coronavirus disease 2019 (COVID-19)
vaccination in persons with prior COVID-19. Methods Employees of the Cleveland Clinic …

COVID‐19 and plasma cells: Is there long‐lived protection?

DC Nguyen, PA Lamothe, MC Woodruff… - Immunological …, 2022 - Wiley Online Library
Summary Infection with SARS‐CoV‐2, the etiology of the ongoing COVID‐19 pandemic, has
resulted in over 450 million cases with more than 6 million deaths worldwide, causing global …

Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design

HH Ayoub, M Tomy, H Chemaitelly… - American Journal of …, 2024 - academic.oup.com
The COVID-19 pandemic has highlighted the need to use infection testing databases to
rapidly estimate effectiveness of prior infection in preventing reinfection () by novel severe …

Immunity to SARS-CoV-2: what do we know and should we be testing for it?

A Misra, ES Theel - Journal of clinical microbiology, 2022 - journals.asm.org
ABSTRACT Preexisting immunity to Severe Acute Respiratory Syndrome Coronavirus-2
(SARS-CoV-2) was nonexistent in humans, which coupled with high transmission rates of …